On Jun. 8, 2020, Evotec announced that its Seattle-based subsidiary Just – Evotec Biologics had entered into an agreement with Advanced BioScience Laboratories (ABL), a global contract development and manufacturing organisation (“CDMO”) to the U.S. Government and biopharmaceutical industry. This project was 100% funded with Federal funds under a $ 318.5 millon contract from the National Institute of Allergy and Infectious Diseases.